Cargando…
Mutational and gene fusion analyses of primary large cell and large cell neuroendocrine lung cancer
Large cell carcinoma with or without neuroendocrine features (LCNEC and LC, respectively) constitutes 3–9% of non-small cell lung cancer but is poorly characterized at the molecular level. Herein we analyzed 41 LC and 32 LCNEC (including 15 previously reported cases) tumors using massive parallel se...
Autores principales: | Karlsson, Anna, Brunnström, Hans, Lindquist, Kajsa Ericson, Jirström, Karin, Jönsson, Mats, Rosengren, Frida, Reuterswärd, Christel, Cirenajwis, Helena, Borg, Åke, Jönsson, Per, Planck, Maria, Jönsson, Göran, Staaf, Johan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673143/ https://www.ncbi.nlm.nih.gov/pubmed/26124082 |
Ejemplares similares
-
Clinical framework for next generation sequencing based analysis of treatment predictive mutations and multiplexed gene fusion detection in non-small cell lung cancer
por: Lindquist, Kajsa Ericson, et al.
Publicado: (2017) -
Clinical Utility of Targeted Sequencing in Lung Cancer: Experience From an Autonomous Swedish Health Care Center
por: Isaksson, Sofi, et al.
Publicado: (2020) -
A combined gene expression tool for parallel histological prediction and gene fusion detection in non-small cell lung cancer
por: Karlsson, Anna, et al.
Publicado: (2019) -
Targeted sequencing may facilitate differential diagnostics of pulmonary tumours: a case series
por: Ericson-Lindquist, Kajsa, et al.
Publicado: (2017) -
CA 19-9 and CA 125 as potential predictors of disease recurrence in resectable lung adenocarcinoma
por: Isaksson, Sofi, et al.
Publicado: (2017)